Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Director dealings: British Land CEO sells down, Ashley settles more Frasers options

(Sharecast News) - Frasers Group was once again on both sides of the ledger on Thursday, after Mike Ashley exercised and settled a number of put options, and purchased further derivatives. The retailer said put options sold by Ashley over 150,000 of its shares, with a strike price of 900p and an expiry of September, had been exercised and were settled through the purchase of derivatives equivalent to 150,000 shares.

It said Ashley also purchased further derivatives equivalent to 100,000 of its shares.

The firm also disclosed that MASH Holdings - a company through which Mike Ashley held shares - sold share-settled put options over 800,000 shares equivalent, with a strike price of 800p and an expiry of September.

Elsewhere, British Land disclosed the sale of more than 42,000 shares by its chief executive officer on 24 May.

The company said Simon Carter sold the shares in three tranches, with the first consisting of 8,967 shares at a price of 356.85p.

It said the second tranche was of 16,789 shares at 357.37p apiece, and the third and final tranche saw 16,836 shares sold for 356.37p each.

At 1614 BST, shares in British Land were down 0.39% at 355.2p, while those in Frasers Group were 3.61% weaker at 680p.

Reporting by Josh White for Sharecast.com.

DIRECTOR SELLS

Company: Frasers Group Name: MASH Holdings Volume: 800,000 Price: 800p Value: £6,400,000.00

Company: London Stock Exchange Group Name: York Holdings II Volume: 19,484 Price: 8,300.79p Value: £1,617,325.92

Company: Tesco Name: Adrian Morris Volume: 590,898 Price: 267.97p Value: £1,583,399.83

Company: Frasers Group Name: Michael Ashley Volume: 150,000 Price: 900p Value: £1,350,000.00

Company: Tesco Name: Jason Tarry Volume: 188,417 Price: 267.56p Value: £504,126.64

Company: Tesco Name: Christine Heffernan Volume: 175,000 Price: 265.1p Value: £463,925.00

Company: Tesco Name: Alessandra Bellini Volume: 161,923 Price: 266.94p Value: £432,229.16

Company: Tesco Name: Gerry Mallon Volume: 150,000 Price: 266.68p Value: £400,015.50

Company: Tesco Name: Adrian Morris Volume: 143,711 Price: 267.53p Value: £384,471.48

Company: Unilever Name: Sanjiv Mehta Volume: 7,976 Price: 4,278.17p Value: £341,226.58

Company: Imperial Brands Name: Alison Clarke Volume: 7,183 Price: 1,799.41p Value: £129,251.97

Company: Energean Name: Nick Witney Volume: 3,670 Price: 1,130.4p Value: £41,485.68

Company: BT Group Name: Harmeen Mehta Volume: 25,850 Price: 146p Value: £37,741.00

Company: Harbour Energy Name: Linda Z Cook Volume: 6,352 Price: 244.1p Value: £15,505.23

DIRECTOR BUYS

Company: Frasers Group Name: Michael Ashley| Volume: 150,00 Price: 901p Value: £1,351,500.00

Company: Frasers Group Name: Michael Ashley Volume: 100,000 Price: 706p Value: £706,000.00

Company: Ninety One Name: Forty Two Point Two Volume: 110,000 Price: 164p Value: £180,400.00

Company: VinaCapital Vietnam Opportunity Fund Name: Asia Investment and Finance Volume: 28,096 Price: 429.13p Value: £120,567.10

Company: Aviva Name: Kristine Cooper Volume: 23,225 Price: 426.29p Value: £99,005.67

Company: Ninety One Name: Forty Two Point Two Volume: 44,011 Price: 162p Value: £71,297.82

Company: British Land Company Name: Simon Carter Volume: 16,789 Price: 357.37p Value: £59,998.85

Company: British Land Company Name: Simon Carter Volume: 16,836 Price: 356.37p Value: £59,998.45

Company: Aviva Name: Adam Winslow Volume: 9,933 Price: 426.29p Value: £42,343.31

Company: Aviva Name: Jason Storah Volume: 9,866 Price: 426.29p Value: £42,057.69

Company: SSE Name: John Bason Volume: 2,117 Price: 1,889.45p Value: £39,999.66

Company: British Land Company Name: Simon Carter Volume: 8,967 Price: 356.85p Value: £31,998.74

Company: Aviva Name: Douglas Brown Volume: 4,227 Price: 426.29p Value: £18,019.24

Company: Aviva Name: Mark Verse Volume: 3,590 Price: 426.29p Value: £15,303.78

Company: Aviva Name: Michael Craston Volume: 1,494 Price: 426.29p Value: £6,368.76

Company: Ninety One Name: Forty Two Point Two Volume: 2,338 Price: 165p Value: £3,857.70

Company: Centrica Name: Amber Rudd Volume: 2,105 Price: 115.91p Value: £2,439.97

Company: Aviva Name: Philippa Lambert Volume: 402 Price: 426.29p Value: £1,713.68

Company: Aviva Name: Mark Versey Volume: 288 Price: 423.12p Value: £1,218.57

Company: Aviva Name: Kristine Cooper Volume: 225 Price: 423.12p Value: £952.01

Company: Aviva Name: Douglas Brown Volume: 66 Price: 423.12p Value: £279.26

Company: Aviva Name: Adam Winslow Volume: 63 Price: 423.12p Value: £266.56

Company: Aviva Name: Jason Storah Volume: 47 Price: 423.12p Value: £198.86

Company: Quilter Name: Penny Cole Volume: 56 Price: 84.55p Value: £47.35

Company: Quilter Name: Stephen Gazard Volume: 56 Price: 84.55p Value: £47.35

Company: Quilte Name: Steven Levin Volume: 56 Price: 84.55p Value: £47.35

Company: Quilter Name: Andy McGlone Volume: 56 Price: 84.55p Value: £47.35

Company: Quilter Name: Nick Sacre-Hardy Volume: 56 Price: 84.55p Value: £47.35

Company: Quilter Name: Mark Satchel Volume: 56 Price: 84.55p Value: £47.35

Share this article

Related Sharecast Articles

Director dealings: Blue Coast raises stake in Everyman Media
(Sharecast News) - Everyman Media revealed on Thursday that Blue Coast had acquired 50,000 ordinary shares in the AIM-listed cinema group.
Director dealings: Angus Energy CEO ups stake
(Sharecast News) - Angus Energy revealed on Wednesday that chief executive Richard Herbert had acquired 5.0m ordinary shares in the AIM-listed onshore oil and gas development firm.
Director dealings: Abrdn CEO makes share sale
(Sharecast News) - Abrdn revealed on Monday that chief executive Stephen Bird had disposed of 29,942 ordinary shares in the FTSE 250-listed global investment company.
Director dealings: Redx Pharma CEO ups stake
(Sharecast News) - Redx Pharma revealed on Friday that chief executive Lisa Anson had acquired 399,000 ordinary shares in the AIM-listed clinical-stage biopharmaceutical firm.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.